II Imunon, Inc. Stock: price and insider trades · United States · SEC (Form 4)Track the Imunon, Inc. share price and the full directors' dealings record of the company, a listed issuer based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €9m. The latest transaction was filed on 1 September 2026 (Attribution). Among the most active insiders: Eylward Susan. All data is openly available.
Analyst consensus: bullish or bearish? Analysts rate Imunon, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$17.00.
Buys €72,287 €15,162 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 1 September 2026
All Executives46 Thresholds0 Prospectus0 Other0
Declarations 46 total
◆ Chief Medical Officer · Executives · 28 Aug 2026
3,626 shares @ US$1.60 Common Stock SEC:0001437749-26-029407:0
◆ President and CEO · Executives · 28 Aug 2026
6,822 shares @ US$1.60 Common Stock SEC:0001437749-26-029408:0
◆ Executive Chairman of Board · Executives · 28 Aug 2026
7,371 shares @ US$1.60 Common Stock SEC:0001437749-26-029409:0
◆ General Counsel and Corp Sec · Executives · 28 Aug 2026
2,525 shares @ US$1.60 Common Stock SEC:0001437749-26-029405:0
▼ General Counsel and Corp Sec · Executives · 31 Aug 2026
2,525 shares @ US$1.5643 Common Stock SEC:0001437749-26-029405:1
◆ General Counsel and Corp Sec · Executives · 14 Aug 2026
2,449 shares @ US$1.65 0.044% mcap 14.7% of flow Common Stock SEC:0001437749-26-028184:0
▼ General Counsel and Corp Sec · Executives · 17 Aug 2026
2,449 shares @ US$1.6303 0.043% mcap 14.5% of flow Common Stock SEC:0001437749-26-028184:1
◆ Chief Medical Officer · Executives · 14 Aug 2026
3,516 shares @ US$1.65 0.063% mcap 29.3% of flow Common Stock SEC:0001437749-26-028186:0
◆ Executive Chairman of Board · Executives · 14 Aug 2026
7,147 shares @ US$1.65 0.13% mcap 17.9% of flow Common Stock SEC:0001437749-26-028185:0
◆ President and CEO · Executives · 14 Aug 2026
6,615 shares @ US$1.65 0.12% mcap 18.6% of flow Common Stock SEC:0001437749-26-028187:0
◆ General Counsel and Corp Sec · Executives · 31 Jul 2026
2,541 shares @ US$1.59 0.046% mcap 20.9% of flow Common Stock SEC:0001437749-26-025661:0
▼ General Counsel and Corp Sec · Executives · 3 Aug 2026
2,541 shares @ US$1.5651 0.045% mcap 20.5% of flow Common Stock SEC:0001437749-26-025661:1
◆ Chief Medical Officer · Executives · 31 Jul 2026
3,649 shares @ US$1.59 0.066% mcap 41.5% of flow Common Stock SEC:0001437749-26-025658:0
◆ Director · Executives · 31 Jul 2026
6,934 shares @ US$1.59 0.13% mcap 17.7% of flow Common Stock SEC:0001437749-26-025665:0
◆ Executive Chairman of Board · Executives · 31 Jul 2026
6,358 shares @ US$1.59 0.12% mcap 18.7% of flow Common Stock SEC:0001437749-26-025660:0
◆ Director · Executives · 31 Jul 2026
6,934 shares @ US$1.59 0.13% mcap 34.9% of flow Common Stock SEC:0001437749-26-025671:0
◆ Director · Executives · 31 Jul 2026
6,934 shares @ US$1.59 0.13% mcap 16.8% of flow Common Stock SEC:0001437749-26-025667:0
◆ Director · Executives · 31 Jul 2026
6,180 shares @ US$1.59 0.11% mcap 14.1% of flow Common Stock SEC:0001437749-26-025663:0
◆ President and CEO · Executives · 31 Jul 2026
5,010 shares @ US$1.59 0.091% mcap 16.7% of flow Common Stock SEC:0001437749-26-025655:0
◆ Chief Medical Officer · Executives · 17 Jul 2026
3,082 shares @ US$1.83 0.073% mcap 69.3% of flow Common Stock SEC:0001437749-26-023947:0
◆ President and CEO · Executives · 17 Jul 2026
4,907 shares @ US$1.83 0.12% mcap 22.8% of flow Common Stock SEC:0001437749-26-023946:0
▼ General Counsel and Corp Sec · Executives · 20 Jul 2026
2,150 shares @ US$1.7816 0.050% mcap 34.0% of flow Common Stock SEC:0001437749-26-023948:1
◆ Executive Chairman of Board · Executives · 17 Jul 2026
4,603 shares @ US$1.83 0.11% mcap 19.3% of flow Common Stock SEC:0001437749-26-023949:0
◆ General Counsel and Corp Sec · Executives · 17 Jul 2026
2,150 shares @ US$1.83 0.051% mcap 34.9% of flow Common Stock SEC:0001437749-26-023948:0
◆ General Counsel and Corp Sec · Executives · 2 Jul 2026
920 shares @ US$1.91 0.021% mcap 50.4% of flow Common Stock SEC:0001437749-26-022944:0
25 of 46 declarations
Load more (21 remaining) 关于 Imunon, Inc. Imunon, Inc. 是一家专注于开发免疫疗法治疗的公司。它旨在为严重疾病提供创新解决方案。